Trials / Recruiting
RecruitingNCT05673096
Paediatric Autism Communication Therapy (PACT) in Children With Autism Spectrum Disorder
Paediatric Autism Communication Therapy (PACT) Combined With Management as Usual Compared to Management as Usual Alone in Children With Autism Spectrum Disorder - a Pragmatic, National, Randomised Clinical Trial
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 280 (estimated)
- Sponsor
- University of Southern Denmark · Academic / Other
- Sex
- All
- Age
- 2 Years – 6 Years
- Healthy volunteers
- Not accepted
Summary
Paediatric Autism Communication Therapy (PACT) is a naturalistic developmental behavioural interventions to reduce autism symptoms. The aim of this trial is to assess the beneficial and harmful effects of PACT in 2-6 year-old children with a recent diagnosis of autism spectrum disorder.
Detailed description
Autism spectrum disorder (ASD) is a neurodevelopmental disorder affecting approximately 2% of children and young people worldwide. ASD is considered a lifelong disorder and interventions significantly reducing the core autistic symptoms have been sparse. Paediatric Autism Communication Therapy (PACT) is among the first naturalistic developmental behavioural interventions to show promising results for reduction in autism symptoms. The aim of this trial is to assess the beneficial and harmful effects of PACT in 2-6 year-old children with a recent diagnosis of ASD. This trial is an investigator-initiated, independently funded, pragmatic, national, parallel group, superiority, randomised clinical trial comparing PACT combined with management as usual to management as usual alone.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | PACT | Paediatric Autism Communication Therapy |
| BEHAVIORAL | MAU | Management as usual |
Timeline
- Start date
- 2023-03-13
- Primary completion
- 2026-03-01
- Completion
- 2026-12-31
- First posted
- 2023-01-06
- Last updated
- 2024-12-11
Locations
6 sites across 1 country: Denmark
Source: ClinicalTrials.gov record NCT05673096. Inclusion in this directory is not an endorsement.